Information  X 
Enter a valid email address

Bank of Montreal (94DW)

  Print   

Thursday 10 March, 2022

Bank of Montreal

Publication of Final Terms

RNS Number : 2700E
Bank of Montreal
09 March 2022
 

Publication of Final Terms

 

Bank of Montreal

9 March 2022

 

The following final terms dated 7 March 2022 and relating to the series CBL27 covered bonds issued on 9 March 2022 under the U.S.$32 billion Global Registered Covered Bond Program of The Bank of Montreal (the Final Terms) are available for viewing:

 

£600,000,000 Floating Rate Covered Bonds due 9 March 2027

 

The Final Terms should be read and construed in conjunction with the Prospectus dated 6 August 2021, the first supplemental Prospectus dated 25 August 2021, the second supplemental Prospectus dated 6 January 2022 and the third supplemental Prospectus dated 1 March 2022 (the Prospectus).

 

To view the full document, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/2700E_1-2022-3-9.pdf

 

A copy of the above Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at:

 

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

For further information, please contact:

 

Sara Virani

Corporate Secretary's Dept.

Bank of Montreal

100 King Street West

1 First Canadian Place, 21st Floor

Toronto, ON M5X 1A1

Phone: (437) 244-9439

Email: [email protected]

 

DISCLAIMER - INTENDED ADDRESSEES

 

This announcement is a communication to the market. Nothing in this announcement constitutes an offer of securities for sale in the United States or any other jurisdiction. This announcement does not constitute a prospectus or a prospectus equivalent document.

 

This announcement has been delivered to you on the basis that you are a person into whose possession this announcement may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver this announcement to any other person. The distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

Likewise, the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

In particular, this announcement and the Final Terms do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Final Terms are not for distribution in the United States or to U.S. persons (as defined below). The securities described herein have not been, and will not be, registered under the Securities Act or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the U.S. Securities Act of 1933, as amended (the Securities Act)) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Prospectus.

 

Your right to access this service is conditional upon complying with the above requirement.  

 

End.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBKCBDKBKBKNK

a d v e r t i s e m e n t